137 related articles for article (PubMed ID: 35450917)
1. Association between proton pump inhibitor use and risk of pneumonia in children: nationwide self-controlled case series study in Sweden.
Wang YH; Svanström H; Wintzell V; Ludvigsson JF; Pasternak B
BMJ Open; 2022 Apr; 12(4):e060771. PubMed ID: 35450917
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study.
Maret-Ouda J; Panula J; Santoni G; Xie S; Lagergren J
J Gastroenterol; 2023 Aug; 58(8):734-740. PubMed ID: 37314495
[TBL] [Abstract][Full Text] [Related]
3. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324
[TBL] [Abstract][Full Text] [Related]
4. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
[TBL] [Abstract][Full Text] [Related]
5. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.
Othman F; Crooks CJ; Card TR
BMJ; 2016 Nov; 355():i5813. PubMed ID: 28715344
[No Abstract] [Full Text] [Related]
6. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
Varma S; Trudeau SJ; Li J; Freedberg DE
Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215
[TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
8. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
[TBL] [Abstract][Full Text] [Related]
9. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
10. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children.
Lassalle M; Zureik M; Dray-Spira R
JAMA Pediatr; 2023 Oct; 177(10):1028-1038. PubMed ID: 37578761
[TBL] [Abstract][Full Text] [Related]
12. Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy.
Holmberg D; Mattsson F; Xie S; Ness-Jensen E; El-Serag H; Lagergren J
J Gastroenterol; 2022 Dec; 57(12):942-951. PubMed ID: 36258093
[TBL] [Abstract][Full Text] [Related]
13. Association of Proton Pump Inhibitors With Hospitalization Risk in Children With Oropharyngeal Dysphagia.
Duncan DR; Mitchell PD; Larson K; McSweeney ME; Rosen RL
JAMA Otolaryngol Head Neck Surg; 2018 Dec; 144(12):1116-1124. PubMed ID: 30325987
[TBL] [Abstract][Full Text] [Related]
14. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
[TBL] [Abstract][Full Text] [Related]
15. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
Sarkar M; Hennessy S; Yang YX
Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
[TBL] [Abstract][Full Text] [Related]
16. Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
JAMA; 2018 Dec; 320(21):2221-2230. PubMed ID: 30512099
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
19. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors.
Ho SW; Tsai MC; Teng YH; Yeh YT; Wang YH; Yang SF; Yeh CB
BMJ Open; 2014 Nov; 4(11):e006710. PubMed ID: 25384687
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs.
Ramsay EN; Pratt NL; Ryan P; Roughead EE
BMC Med Res Methodol; 2013 Jun; 13():82. PubMed ID: 23800078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]